Cargando…

Clostridioides difficile toxin is infrequently detected in inflammatory bowel disease and does not associate with clinical outcomes

INTRODUCTION: Clostridioides difficile infection (CDI) rates and outcomes can vary based on differences in testing strategy. Our aim was to assess the prevalence of toxin detection in inflammatory bowel disease (IBD) when compared to those without IBD. Secondly, the clinical outcomes of CDI in IBD w...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bernard, Rachel, Hammami, Muhammad B., Arnold, Forest W., Mcgrath, Brian, Patel, Alieysa, Wuerth, Brandon, Nicholson, Maribeth R., Rao, Krishna, Micic, Dejan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Brief Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9426007/ https://www.ncbi.nlm.nih.gov/pubmed/36042530 http://dx.doi.org/10.1186/s13099-022-00511-2

Ejemplares similares

2409. External Validation and Comparison of Clostridioides difficile Severity Scoring Systems
por: Perry, Donald A, et al.
Publicado: (2019)

Clostridioides difficile infection surveillance in intensive care units and oncology wards using machine learning
por: Ötleş, Erkin, et al.
Publicado: (2023)

17. Comparative Assessment of a Machine Learning Model and Rectal Swab Surveillance to Predict Hospital Onset Clostridioides difficile
por: Ötleş, Erkin, et al.
Publicado: (2021)

An Update on Clostridioides difficile Binary Toxin
por: Martínez-Meléndez, Adrián, et al.
Publicado: (2022)

Cytotoxic synergism of Clostridioides difficile toxin B with proinflammatory cytokines in subjects with inflammatory bowel diseases
por: Bassotti, Gabrio, et al.
Publicado: (2023)

The prognostic value of toxin B and binary toxin in Clostridioides difficile infection
por: López-Cárdenas, Salvador, et al.
Publicado: (2021)

Host Immune Responses to Clostridioides difficile: Toxins and Beyond
por: Nibbering, Britt, et al.
Publicado: (2021)

Structure and conformational dynamics of Clostridioides difficile toxin A
por: Chen, Baohua, et al.
Publicado: (2022)

Non-Toxin-Based Clostridioides difficile Vaccination Approaches
por: Razim, Agnieszka, et al.
Publicado: (2023)

Diversity of binary toxin positive Clostridioides difficile in Korea
por: Kim, Jieun, et al.
Publicado: (2023)

RstA Is a Major Regulator of Clostridioides difficile Toxin Production and Motility
por: Edwards, Adrianne N., et al.
Publicado: (2019)

4345 Two-step Algorithm for Clostridioides difficile is Inadequate for Differentiating Infection from Colonization in Children
por: Nicholson, Maribeth R, et al.
Publicado: (2020)

The interplay of Clostridioides difficile infection and inflammatory bowel disease
por: Sehgal, Kanika, et al.
Publicado: (2021)

Rho factor mediates flagellum and toxin phase variation and impacts virulence in Clostridioides difficile
por: Trzilova, Dominika, et al.
Publicado: (2020)

Impact of deoxycholate on Clostridioides difficile growth, toxin production, and sporulation
por: Usui, Yukino, et al.
Publicado: (2020)

The Importance of Therapeutically Targeting the Binary Toxin from Clostridioides difficile
por: Abeyawardhane, Dinendra L., et al.
Publicado: (2021)

Binary Toxin Expression by Clostridioides difficile Is Associated With Worse Disease
por: Young, Mary K, et al.
Publicado: (2022)

Iron Effects on Clostridioides difficile Toxin Production and Antimicrobial Susceptibilities
por: Yamaki, Jason, et al.
Publicado: (2022)

Tauroursodeoxycholic Acid Inhibits Clostridioides difficile Toxin-Induced Apoptosis
por: Pike, Colleen M., et al.
Publicado: (2022)

The cytotoxic synergy between Clostridioides difficile toxin B and proinflammatory cytokines: an unholy alliance favoring the onset of Clostridioides difficile infection and relapses
por: Bassotti, Gabrio, et al.
Publicado: (2020)

54101 Characterizing Microbiota Features of Clostridioides difficile Infections
por: Tomkovich, Sarah, et al.
Publicado: (2021)

791. Evaluation of NSAID Exposure as a Risk Factor for Clostridium difficile infection: A Propensity-Score-Matched Case-Control Study
por: Ressler, Adam M, et al.
Publicado: (2020)

Management of Clostridioides difficile infection in patients with inflammatory bowel disease
por: Khanna, Sahil
Publicado: (2021)

Inhibition of Clostridioides difficile Toxins TcdA and TcdB by Ambroxol
por: Heber, Sebastian, et al.
Publicado: (2022)

Glucosyltransferase-dependent and independent effects of Clostridioides difficile toxins during infection
por: Peritore-Galve, F. Christopher, et al.
Publicado: (2022)

Characterization and Pharmacological Inhibition of the Pore-Forming Clostridioides difficile CDTb Toxin
por: Ernst, Katharina, et al.
Publicado: (2021)

Structural Basis for Binding of Neutralizing Antibodies to Clostridioides difficile Binary Toxin
por: Goldsmith, Jory A., et al.
Publicado: (2023)

The TcdE holin drives toxin secretion and virulence in Clostridioides difficile
por: DiBenedetto, NV, et al.
Publicado: (2023)

The Current Knowledge on Clostridioides difficile Infection in Patients with Inflammatory Bowel Diseases
por: Boeriu, Alina, et al.
Publicado: (2022)

Expression and (Lacking) Internalization of the Cell Surface Receptors of Clostridioides difficile Toxin B
por: Schöttelndreier, Dennis, et al.
Publicado: (2018)

Metabolic Reprogramming of Clostridioides difficile During the Stationary Phase With the Induction of Toxin Production
por: Hofmann, Julia D., et al.
Publicado: (2018)

The Conserved Cys-2232 in Clostridioides difficile Toxin B Modulates Receptor Binding
por: Chung, Soo-Young, et al.
Publicado: (2018)

Eosinopenia and Binary Toxin Increase Mortality in Hospitalized Patients With Clostridioides difficile Infection
por: Carlson, Travis J, et al.
Publicado: (2020)

Structural Insights into the Transition of Clostridioides difficile Binary Toxin from Prepore to Pore
por: Anderson, David M., et al.
Publicado: (2019)

2398. Effect of Eosinopenia and Binary Toxin on Clostridioides difficile Infection Clinical Outcomes
por: Carlson, Travis J, et al.
Publicado: (2019)

The Binary Toxin of Clostridioides difficile Alters the Proteome and Phosphoproteome of HEp-2 Cells
por: Stieglitz, Florian, et al.
Publicado: (2021)

Proinflammatory Cytokines: Possible Accomplices for the Systemic Effects of Clostridioides difficile Toxin B
por: Fettucciari, Katia, et al.
Publicado: (2021)

Low-toxin Clostridioides difficile RT027 strains exhibit robust virulence
por: Anwar, Farhan, et al.
Publicado: (2022)

Structure-guided design of a potent Clostridioides difficile toxin A inhibitor
por: Hussack, Greg, et al.
Publicado: (2023)

386. Clostridioides difficile PCR Cycle Threshold to Determine Toxin Positivity Status
por: Crone, Andrew S, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_uu3fj8sn8mg34ld52v74ognb73